Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study

The objective of this study was to evaluate the risk for cancer patients of developing a new primary invasive cancer. Using data from a French Cancer Registry, we included 14 353 cancer patients (breast, colorectal or prostate cancer) diagnosed between 1989 and 1997. Observed second cancers occurring during the first 5 years after the first cancer were compared with the expected number, based on primary cancer incidence rate, by the standardized incidence ratio (SIR). Breast cancer patients had significantly elevated SIR for contralateral breast cancer (SIR=1.7), kidney cancer (SIR=3.5) and myeloid leukaemia (SIR=8.3). Patients diagnosed with colorectal cancer had significantly elevated risk for small intestine (SIR=10.7) and colorectal cancer (SIR=1.6). Young age at diagnosis of breast and colorectal cancers was associated with risk of a second cancer. After prostate cancer, men had no greater risk of cancer, except for kidney cancer. Our results help to direct attention to regions especially vulnerable to secondary cancers after primary breast or colorectal cancer.

[1]  Michael Hauptmann,et al.  Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M Colonna,et al.  Cancer incidence and mortality in France over the period 1980-2005. , 2008, Revue d'epidemiologie et de sante publique.

[3]  J. Coebergh,et al.  Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Soloway,et al.  Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk? , 2007, European urology.

[5]  Elisabeth G. E. de Vries,et al.  The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands , 2007, Breast Cancer Research and Treatment.

[6]  H. Brenner,et al.  Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  G. Launoy,et al.  Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). , 2007, European journal of cancer.

[8]  Matthew J Hayat,et al.  Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. , 2007, The oncologist.

[9]  K. Hemminki,et al.  Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology , 2007, Breast Cancer Research and Treatment.

[10]  M. Goodman,et al.  Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975–2001 , 2006, Cancer.

[11]  J. Olsen,et al.  Risk of second cancer among women with breast cancer , 2006, International journal of cancer.

[12]  A. Neugut,et al.  Incidences and Trends of Second Cancers in Female Breast Cancer Patients: A Fixed Inception Cohort-based Analysis (United States) , 2006, Cancer Causes & Control.

[13]  A. Lesur,et al.  Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l‘ovaire (mise à jour 2004) , 2004 .

[14]  H. Sobol,et al.  [Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)]. , 2004, Bulletin du cancer.

[15]  J. Fraumeni,et al.  Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer. , 2004, Journal of the National Cancer Institute.

[16]  E. Kliewer,et al.  Incidence of Second Primary Breast Cancer Among Women with a First Primary in Manitoba, Canada , 2001, Breast Cancer Research and Treatment.

[17]  C. Rubino,et al.  Increased risk of second cancers following breast cancer: Role of the initial treatment , 2000, Breast Cancer Research and Treatment.

[18]  J. Hopper,et al.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.

[19]  C. la Vecchia,et al.  Cancer risk in women with previous breast cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  C. Lewis,et al.  The risk of subsequent primary cancers after colorectal cancer in southeast England , 2002, Gut.

[21]  E. Buiatti,et al.  Multiple primary cancer incidence in Italy. , 2001, European journal of cancer.

[22]  Jeffrey S. Morris,et al.  Effect of age on risk of second primary colorectal cancer. , 2001, Journal of the National Cancer Institute.

[23]  K. Hemminki,et al.  Second primary neoplasms in 633,964 cancer patients in Sweden, 1958–1996 , 2001, International journal of cancer.

[24]  K. Hemminki,et al.  Second primary cancers after sporadic and familial colorectal cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  C. Lewis,et al.  Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England , 2001, British Journal of Cancer.

[26]  K. Hemminki,et al.  Risk factors and age‐incidence relationships for contralateral breast cancer , 2000, International journal of cancer.

[27]  H. Hollema,et al.  Risk and prognosis of endometrial cancer after tamoxifen for breast cancer , 2000, The Lancet.

[28]  C. Bonithon-Kopp,et al.  Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  I. Ellis,et al.  Clinical and histological predictors of contralateral breast cancer. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[30]  F Levi,et al.  Second primary tumors after prostate carcinoma , 1999, Cancer.

[31]  M. McCredie,et al.  Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[32]  R. Sankila,et al.  Risk of subsequent malignant neoplasms among 470,000 cancer patients in Finland, 1953‐1991 , 1995, International journal of cancer.

[33]  L. Ries,et al.  Leukemia following chemotherapy for breast cancer. , 1990, Cancer research.